Kazuya Sato

11PUBLICATIONS
27CO-AUTHORS
Gene and molecular therapyHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 21, 2026
The Natural Quassinoid Brusatol Enhances Venetoclax Efficacy and Overcomes Resistance in Myeloid Leukemias.

|Mar 07, 2026
Cost-effectiveness of blinatumomab as post-remission therapy in adults with measurable residual disease-negative, Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.

Chihiro Yamamoto, Teruaki Yamaguchi, Seina Honda

|Oct 21, 2025
The combination of venetoclax with dimethyl fumarate synergistically induces apoptosis in AML cells by disrupting mitochondrial integrity through ROS accumulation.

Shin-Ichiro Kawaguchi, Kazuya Sato, Junko Izawa

|Mar 05, 2024
Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease.

Hirofumi Nakano, Kazuya Sato, Junko Izawa

|Nov 08, 2023
Forodesine Enhances Immune Responses through Guanosine-Mediated TLR7 Activation while Preventing Graft-versus-Host Disease.

Takashi Ikeda, Kazuya Sato, Shin-Ichiro Kawaguchi

|Jun 26, 2023
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.

Kento Umino, Kaoru Morita, Takashi Ikeda

Pageof 2

Frequent Collaborators

6 joint publications

Chihiro Yamamoto

5 joint publications

Yoshinobu Kanda

4 joint publications

Shin-Ichiro Fujiwara

3 joint publications

Kiyomi Mashima